ICUI - ICU Medical Inc Stock Price, Fair Value and News

$156.82+3.62 (+2.36%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

ICUI Price Action

Last 7 days

-3.0%

Last 30 days

-6.4%

Last 90 days

-11.3%

Trailing 12 Months

59.3%

ICUI RSI Chart

ICUI Valuation

Market Cap

3.8B

Price/Earnings (Trailing)

-34.59

Price/Sales (Trailing)

1.64

EV/EBITDA

100.71

Price/Free Cashflow

22.6

ICUI Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ICUI Fundamentals

ICUI Revenue

Revenue (TTM)

2.3B

Rev. Growth (Yr)

6.47%

Rev. Growth (Qtr)

-1.23%

ICUI Earnings

Earnings (TTM)

-111.0M

Earnings Growth (Yr)

-555.69%

Earnings Growth (Qtr)

-54.08%

ICUI Profitability

Operating Margin

34.87%

EBT Margin

-3.40%

Return on Equity

-5.42%

Return on Assets

-2.58%

Free Cashflow Yield

4.42%

ICUI Investor Care

Shares Dilution (1Y)

1.43%

Diluted EPS (TTM)

-4.57

ICUI Alerts

4 major insider sales recently.
JANUS HENDERSON GROUP PLC reported owning 9.9% of ICUI [2024-11-14]
Big fall in earnings (Y/Y)
Losses in recent quarter

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	2.3B	2.3B	2.3B	0
2023	2.3B	2.3B	2.2B	2.3B
2022	1.5B	1.8B	2.0B	2.3B
2021	1.3B	1.3B	1.3B	1.3B
2020	1.3B	1.3B	1.3B	1.3B
2019	1.4B	1.3B	1.3B	1.3B
2018	1.4B	1.4B	1.4B	1.4B
2017	537.3M	772.0M	1.0B	1.3B
2016	350.0M	363.0M	374.1M	379.4M
2015	317.5M	322.6M	331.2M	341.7M
2014	312.6M	312.7M	307.3M	309.3M
2013	315.7M	317.0M	318.4M	313.7M
2012	306.2M	305.7M	310.7M	316.9M
2011	290.7M	299.9M	300.9M	302.2M
2010	238.4M	253.6M	275.1M	283.0M
2009	0	0	0	229.0M

Get all data in R, Python etc through our Historical Stock Data APIs

About ICU Medical Inc

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; and ClearGuard HD, that maintains hemodialysis catheters. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 brand; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; professional services; critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

CEO	Mr. Vivek Jain
WEBSITE	icumed.com
SECTOR	Healthcare
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	14500

ICU Medical Inc Frequently Asked Questions

What is the ticker symbol for ICU Medical Inc? What does ICUI stand for in stocks?

ICUI is the stock ticker symbol of ICU Medical Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of ICU Medical Inc (ICUI)?

As of Fri Dec 20 2024, market cap of ICU Medical Inc is 3.84 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ICUI stock?

You can check ICUI's fair value in chart for subscribers.

Is ICU Medical Inc a good stock to buy?

The fair value guage provides a quick view whether ICUI is over valued or under valued. Whether ICU Medical Inc is cheap or expensive depends on the assumptions which impact ICU Medical Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ICUI.

What is ICU Medical Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, ICUI's PE ratio (Price to Earnings) is -34.59 and Price to Sales (PS) ratio is 1.64. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ICUI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on ICU Medical Inc's stock?

In the past 10 years, ICU Medical Inc has provided 0.067 (multiply by 100 for percentage) rate of return.